Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

npj Parkinson's Disease (2)
Nature Communications (1)
npj Digital Medicine (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (3)
Amendments and Corrections (1)

Subject Check one or more subjects to show results from those subjects only.

Biomarkers
Chemical biology
Medical research
Molecular biology
Neurology
Neuroscience

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–4 of 4 results

Advanced filters: Author: Tanner W. Eggert Clear advanced filters

Reactivity-dependent profiling of RNA 5-methylcytidine dioxygenases

Kleiner and co-workers profile RNA 5-methylcytidine (m⁵C) dioxygenase enzymes using an activity-based metabolic probing strategy. They reveal ALKBH1 as the major 5-formylcytidine (f⁵C) writer and characterize modification sites across mRNA and tRNA.

A. Emilia Arguello
Ang Li
Ralph E. Kleiner
ResearchOpen Access19 Jul 2022
Nature Communications

Volume: 13, P: 1-17
Exploratory digital outcome measures of motor sign progression in Parkinson’s disease patients treated with prasinezumab

Kirsten I. Taylor
Florian Lipsmeier
Stefano Zanigni
ResearchOpen Access16 Jun 2025
npj Digital Medicine

Volume: 8, P: 1-12
Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials

Gennaro Pagano
Dylan Trundell
Stefano Zanigni
ResearchOpen Access01 Jul 2025
npj Parkinson's Disease

Volume: 11, P: 1-8
Author Correction: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials

Gennaro Pagano
Dylan Trundell
Stefano Zanigni
Amendments and CorrectionsOpen Access13 Aug 2025
npj Parkinson's Disease

Volume: 11, P: 1